fitforthem
about

scope and guide to the platform

—research groups

research groups network graph visualization

—repositories

catalog of the institutional repositories

—heritage

selection of collections, museum, cultural sites and ancient books

By continuing your visit to this site, you accept the use of essential cookies.

Read more
6533b833fe1ef96bd129c323

RESEARCH PRODUCT

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights

Keitiane KaeferPatrick M. HonoreAude MugishaAndrea GalleraniLeonel Barreto GutierrezSebastien RedantDavid De Bels

subject

medicine.medical_specialtyTazobactamLetterContinuous Renal Replacement Therapybusiness.industrymedicine.medical_treatmentCritical IllnessCEFTOLOZANE/TAZOBACTAMlcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RC86-88.9Critical Care and Intensive Care MedicineCephalosporinsmedicineHumansRenal replacement therapyIntensive care medicinebusiness
yearjournalcountryeditionlanguage
2019-12-01Critical Care
10.1186/s13054-019-2692-2https://doaj.org/article/a4d5f9a7928a47b4b6a2d06523624ae9
EU flag

FORTHEM European University Alliance is co-funded by the European Union. FIT FORTHEM has received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No. 101017248. The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission.

University of Jyväskylä logoUniversity of Jyväskylä's websiteUniversity of Burgundy logoUniversity of Burgundy's websiteUniversity of Mainz logoUniversity of Mainz's websiteUniversity of Palermo logoUniversity of Palermo's websiteUniversity of Latvia logoUniversity of Latvia's website
University of Agder logoUniversity of Agder's websiteUniversity of Opole logoUniversity of Opole's websiteUniversity of Sibiu logoUniversity of Sibiu's websiteUniversity of València logoUniversity of València's website
FORTHEM logoFORTHEM alliance's website